Page 527 - ACCCN's Critical Care Nursing

504 P R I N C I P L E S A N D P R A C T I C E O F C R I T I C A L C A R E

30. Chien-Chu Chun, Landon KS, Rabb H. Mechanisms underlying combined 61. Marshal M, Ma T, Galler D, Rankin A, Williams A. Sustained low-efficiency
acute renal failure and acute lung injury in the intensive care unit. Contrib daily diafiltration (SLEDD-f) for critically ill patients requiring renal replace-
Nephrol 2004; 144: 53–62. ment therapy: towards an adequate therapy. Nephrol Dial Transplant 2004;
31. Bataller R, Sort P, Gines P, Arroyo V. Hepatorenal syndrome: definition, 19: 877–84.
pathophysiology, clinical features and management. Kidney Int 1998; 62. Baldwin I, Bellomo R. Sustained low efficiency dialysis in the ICU. Int J Intens
53(Suppl. 66): s47–53. Care 2002; 9: 177–87.
32. Bellomo R, Ronco C, Kellum J, Mehta R, Palevsky P; ADQI working group. 63. Harris DCH, Stewart JH. Dialysis. In: Whitworth JA, Lawrence JR, eds. Text-
Acute renal failure: definition, outcome measures, animal models, fluid book of renal diseases, 2nd edn. Edinburgh: Churchill Livingstone; 1994.
therapy and information technology needs: the Second International Con- 64. Davenport A, Mehta S. The acute dialysis quality initiative–Part VI: access
sensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. and anticoagulation in CRRT. Adv Renal Replace Ther 2002; 9(4): 273–81.
Crit Care 2004; 8(4): R204–212. 65. Ofsthun NJ, Colton CK, Lysaght MJ. Determinants of fluid and solute
33. Bellomo R, Ronco C. Continuous versus intermittent renal replacement removal rates during hemofiltration. In: Henderson LW, Quellhorst G, Bal-
therapy in the intensive care unit. Kidney Int 1998; 53(Suppl 66): s125–8. damus CA, Lysaght MJ, eds. Hemofiltration. Berlin: Springer-Verlag; 1986.
34. Kierdorf H. The nutritional management of acute renal failure in the inten- 66. Ronco C, Bellomo R. Basic mechanisms and definitions for continuous renal
sive care unit. New Horiz 1995; 3(4): 699–707. replacement therapies. Int J Artificial Organs 1996; 19: 95–9.
35. Kierdorf H. Continuous versus intermittent treatment: clinical results in 67. Bellomo R. Hemofiltration. In Ayres SM, Grenvik A, Holbrook PR, Shoe-
acute renal failure. Contrib Nephrol 1991; 93: 1–12. maker WC, eds. Textbook of critical care, 3rd edn. Philadelphia: WB Saunders;
36. Krebs WA, ed. Concise Oxford Dictionary. London: Oxford Press; 1987. 1995. p.1041–53.
37. Cameron JS. Practical haemodialysis began with cellophane and heparin: 68. Winkleman C. Hemofiltration: a new technique in critical care nursing.
the crucial role of William Thalhimer (1884–1961). Nephrol Dial Transplantat Heart Lung 1985; 14(3): 265–71.
2000; 15: 1086–91. 69. Dirkes S. How to use the new CVVH renal replacement systems. Am J Nurs
38. Vienken J, Diamantoglou M, Henne W, Nederlof B. Artificial dialysis mem- 1994; 94: 67–73.
branes: from concept to large scale production. Am J Nephrol 1999; 19: 70. Golper TA, Price J. Continuous veno-venous hemofiltration for acute renal
355–62. failure in the intensive care setting. ASAIO J 1994; 40: 936–9.
39. McBride P. Industry’s contributions to the development of renal care. ANNA 71. Thomas N. Haemodialysis. In Thomas N, ed. Renal nursing, 2nd edn.
J 1989; 16(3): 217–26. London: Baillière Tindall; 2002.
40. Ronco C, La Greca G. The role of technology in hemodialysis. Contrib Nephrol 72. Bellomo R, Ronco C, Mehta R. Technique of continuous renal replacement
2002; 137: 1–12. therapy: nomenclature for continuous renal replacement therapies. Am J
41. Coleman B, Merrill JP. The artificial kidney. Am J Nurs 1952; 52(3): 327–9. Kidney Dis 1996; 28(5 Supp. 3): s2–7.
42. Baldwin I, Elderkin T. Continuous hemofiltration: nursing perspectives in 73. Macias W, Mueller B, Scarim S, Robinson M, Rudy D. Continuous venove-
critical care. New Horizons 1995; 3(4): 738–47. nous hemofiltration: an alternative to continuous arteriovenous hemofiltra-
43. Martin R, Jurschak J. Nursing management of continuous renal replacement tion and hemodiafiltration in acute renal failure. Am J Kidney Dis 1991; 18:
therapy. Semin Dial 1996; 9(2): 192–9. 451–8.
44. Mehta R, Martin R. Initiating and implementing a continuous renal replace- 74. Relton S, Greenberg A, Palevsky P. Dialysate and blood flow dependence of
ment therapy program. Semin Dial 1996; 9(2): 80–7. diffusive solute clearance during CVVHD. ASAIO J 1992; 38(3): M691–6.
45. Ash SR, Wimberly AL, Mertz SL. PD for acute and ESRD: an update. Hosp 75. Ronco C, Bellomo R. Continuous renal replacement therapies: the need for
Pract 1983; 2: 179–210. a standard nomenclature. Contrib Nephrol 1995; 116: 28–33.
46. Wild J. Peritoneal dialysis. In Thomas N, ed. Renal nursing, 2nd edn. London: 76. Yohay DA, Butterly DW, Schwab SJ, Quarles LD. Continuous arteriovenous
Baillière Tindall; 2002. hemodialysis: effect of dialyzer geometry. Kidney Int 1992; 42(2): 448–51.
47. Mehta R, Letteri JM. Current status of renal replacement therapy for acute 77. Uldall R. Vascular access for continuous renal replacement therapy. Semin
renal failure. Am J Nephrol 1999; 19: 377–82. Dial 1996; 9(2): 93–7.
48. Kramer P, Wigger W, Rieger J, Matthaei D, Scheler F. Arteriovenous haemo- 78. Kox WJ, Rohr U, Wauer H. Practical aspects of renal replacement therapy. Int
filtration: a new and simple method for treatment of overhydrated patients J Artificial Organs 1996; 19(2): 100–5.
resistant to diuretics. Klin Wochenschr 1977; 55: 1121–2. 79. Baldwin I, Bellomo R, Koch B. A technique for the monitoring of blood flow
49. Burchardi H. History and development of continuous renal replacement during continuous hemofiltration. Intens Care Med 2002; 28: 1361–4.
techniques. Kidney Int 1998; 53(Suppl 66): S120–24. 80. Webb AR, Mythen MG, Jacobsen D, Mackie IJ. Maintaining blood flow in
50. Bihari DJ. Acute renal failure in the intensive care unit: the role of the spe- the extracorporeal circuit: haemostasis and anticoagulation. Intens Care Med
cialist in intensive care. Semin Dial 1996; 9(2): 204–8. 1995; 21: 84–93.
51. Moreno L, Heyka R, Pagannini E. Continuous renal replacement therapy: 81. Baldwin I. Factors affecting circuit patency and filter life. In: C Ronco, R
cost considerations and reimbursement. Semin Dial 1996; 9(2): 209–14. Bellomo, J Kellum, eds. Contributions to Nephrology, Vol. 156. Basel, Karger
52. Ronco C, Brendolan A, Bellomo R. Current technology for continuous renal 2007. p. 178–84.
replacement therapies. In: Ronco C, Bellomo R, eds. Critical care nephrology. 82. Gretz N, Quintel M, Ragaller M, Odenwalder W, Bender HJ, Rohmeiss SM.
Dordrecht: Kluwer Academic; 1998. Low-dose heparinization for anticoagulation in intensive care patients on
53. Uchino S, Bellomo R, Morimatsu H, Morgera S, Schetz M et al. Continuous continuous hemofiltration. Contrib Nephrol 1995; 116: 130–35.
renal replacement therapy: a worldwide practice survey. The beginning and 83. Langeneker SA, Felfernig M, Werba A, Meuller CM, Chiari A, Zinpfer M.
ending supportive therapy for the kidney (B.E.S.T. kidney) investigators. Anticoagulation with prostacyclin and heparin during continuous venove-
Intens Care Med 2007; 33(9): 1563–70. nous hemofiltration. Crit Care Med 1994; 22(11): 1774–81.
54. Baldwin I, Fealy N. Nursing for renal replacement therapies in the Intensive 84. Cassina T, Mauri R, Engeler A, and Giannini O. Continuous veno-venous
Care Unit: historical, educational, and protocol review. Blood Purification haemofiltration with regional citrate anticoagulation: A four year single
2009 27: 174–81. center experience. Int. Journal of Artificial Organs 2008; 31(11): 937–43.
55. Kaplan A. Current assessment of CRRT: appropriate optimism or unwar- 85. Baldwin I , Tan HK, Bridge N, and Bellomo R. Possible strategies to prolong
ranted enthusiasm? Advances in RRT 2002; 9(4): e4. circuit life during hemofiltration: three controlled studies. Renal Failure 2002;
56. Ronco C, Bellomo R, Kellum J. Continuous renal replacement therapy: 24(6): 839–48.
opinions and evidence. Adv Renal Replace Ther 2002; 9(4): 229–44. 86. Leslie G, Jacobs I, Clarke G. Proximally delivered high volume heparin does
57. Kellum JA, Angus DC, Johnson JP, Leblanc M, Griffin M et al. Continuous not improve circuit life in continuous venovenous haemodiafiltration
versus intermittent renal replacement therapy: a meta-analysis. Intens Care (CVVHD). Intens Care Med 1996; 22: 1261–4.
Med 2002; 28: 29–37. 87. Monchi M, Berghmans D, Ledoux D, Canivet JL, Dubois B, Damas P. Citrate
58. Lameire N, Van Biesen WV, Vanholder R, Colardijn F. The place of intermit- vs. heparin for anticoagulation in continuous venovenous hemofiltration: A
tent hemodialysis in the treatment of acute renal failure in the ICU patient. prospective randomized study. Intens Care Med 2004; 30(7): 260–65.
Kidney Int 1998; 53(Suppl 66): s110–19. 88. Tolwani A, Campbell R, Schenk M, Allon M, Warnock D. (2001) Simplified
59. Van Biesen W, Vanholder R, Lamiere N. Dialysis strategies in critically ill citrate anticoagulation for continuous renal replacement therapy. Kidney Int
acute renal failure patients. Curr Opin Crit Care 2003; 9: 491–5. 2001 60(1): 370–74.
60. Palevsky PM, Zhang JH, O’Connor TZ, Chertow GM et al. Intensity of renal 89. Palsson R, Niles JL. Regional citrate anticoagulation in continuous venove-
support in critically ill patients with acute kidney injury. N Eng J Med 2008; nous hemofiltration in critically ill patients with a high risk of bleeding.
359(1): 7–20. Kidney Int 1999; 55(5), 1991–7.